BIIB240517C00135000 Option on Biogen Inc

BIIB Stock  USD 231.99  4.73  2.00%   
Biogen's latest option contracts expiring on 2024-06-07 are carrying combined implied volatility of 49.73 with a put-to-call open interest ratio of 0.11 over 98 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-06-07. The current put volume is at 37.0, with calls trading at the volume of 207. This yields a 0.18 put-to-call volume ratio.

Open Interest Against 2024-06-07 Option Contracts

The chart above shows Biogen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Biogen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Biogen's option, there is no secondary market available for investors to trade.

Biogen Maximum Pain Price across 2024-06-07 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Biogen close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Biogen's option chain provides insight into all available option contracts written on Biogen's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Biogen's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Biogen option contract.

In The Money vs. Out of Money Option Contracts on Biogen

Analyzing Biogen's in-the-money options over time can help investors to take a profitable long position in Biogen regardless of its overall volatility. This is especially true when Biogen's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Biogen's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Biogen's stock while costing only a fraction of its price.
Biogen's stock options are financial instruments that give investors the right to buy or sell shares of Biogen Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biogen stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biogen's stock price goes up or down, the stock options follow.
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 283 M, whereas Other Stockholder Equity is projected to grow to (2.5 B).

Biogen Inc In The Money Call Balance

When Biogen's strike price is surpassing the current stock price, the option contract against Biogen Inc stock is said to be in the money. When it comes to buying Biogen's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Biogen Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Biogen Current Options Market Mood

Biogen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biogen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Biogen's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Biogen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Biogen's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Biogen contract

Base on the Rule 16, the options market is currently suggesting that Biogen Inc will have an average daily up or down price movement of about 3.11% per day over the life of the 2024-06-07 option contract. With Biogen trading at USD 231.99, that is roughly USD 7.21. If you think that the market is fully incorporating Biogen's daily price movement you should consider buying Biogen Inc options at the current volatility level of 49.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Biogen options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Biogen calls. Remember, the seller must deliver Biogen Inc stock to the call owner when a call is exercised.

Biogen Option Chain

When Biogen's strike price is surpassing the current stock price, the option contract against Biogen Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Biogen's option chain is a display of a range of information that helps investors for ways to trade options on Biogen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biogen. It also shows strike prices and maturity days for a Biogen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-06-07 CALL at $125.00.99751.0E-402024-06-07102.1 - 112.00.0In
Call
2024-06-07 CALL at $130.00.98955.0E-402024-06-0797.5 - 107.00.0In
Call
2024-06-07 CALL at $135.00.99264.0E-402024-06-0792.3 - 102.00.0In
Call
2024-06-07 CALL at $140.00.91420.001502024-06-0787.1 - 96.90.0In
Call
2024-06-07 CALL at $145.00.98756.0E-402024-06-0782.5 - 92.00.0In
Call
2024-06-07 CALL at $150.00.99125.0E-402024-06-0777.3 - 87.00.0In
Call
2024-06-07 CALL at $155.00.99345.0E-402024-06-0772.2 - 82.00.0In
Call
2024-06-07 CALL at $160.00.9935.0E-402024-06-0767.2 - 77.00.0In
Call
2024-06-07 CALL at $165.00.98938.0E-402024-06-0762.3 - 72.00.0In
Call
2024-06-07 CALL at $170.00.98540.001102024-06-0757.4 - 67.00.0In
Call
2024-06-07 CALL at $175.00.98120.001402024-06-0752.5 - 62.00.0In
Call
2024-06-07 CALL at $180.00.97350.001902024-06-0747.7 - 57.00.0In
Call
2024-06-07 CALL at $185.00.97770.00202024-06-0742.5 - 52.00.0In
Call
2024-06-07 CALL at $190.00.96820.002852024-06-0737.7 - 47.035.0In
Call
2024-06-07 CALL at $192.50.95370.003602024-06-0735.1 - 45.00.0In
Call
2024-06-07 CALL at $195.00.96480.003402024-06-0732.7 - 42.00.0In
Call
2024-06-07 CALL at $197.50.94230.004702024-06-0730.3 - 40.00.0In
Call
2024-06-07 CALL at $200.00.96470.00412024-06-0727.6 - 37.019.1In
Call
2024-06-07 CALL at $202.50.95790.004802024-06-0725.6 - 34.10.0In
Call
2024-06-07 CALL at $205.00.95970.005242024-06-0722.8 - 31.814.03In
Call
2024-06-07 CALL at $207.50.94670.006602024-06-0721.0 - 28.80.0In
Call
2024-06-07 CALL at $210.00.96550.005922024-06-0718.1 - 26.321.02In
Call
2024-06-07 CALL at $212.50.77090.010132024-06-0716.0 - 23.818.55In
Call
2024-06-07 CALL at $215.00.94340.0172024-06-0713.3 - 21.316.85In
Call
2024-06-07 CALL at $217.50.96260.0096112024-06-0710.5 - 18.819.47In
Call
2024-06-07 CALL at $220.00.80960.0186452024-06-0711.0 - 16.216.1In
Call
2024-06-07 CALL at $222.50.6910.0164152024-06-075.3 - 14.414.0In
Call
2024-06-07 CALL at $225.00.76660.0303302024-06-073.0 - 11.88.43In
Call
2024-06-07 CALL at $227.50.66310.0317712024-06-071.75 - 9.27.17In
Call
2024-06-07 CALL at $230.00.57730.0326632024-06-072.5 - 7.25.85In
Call
2024-06-07 CALL at $232.50.46370.08451572024-06-070.85 - 2.151.65Out
Call
2024-06-07 CALL at $235.00.23470.076492024-06-070.5 - 1.10.55Out
Call
2024-06-07 CALL at $237.50.19470.0445512024-06-070.1 - 1.550.66Out
Call
2024-06-07 CALL at $240.00.09250.02834772024-06-070.2 - 2.550.25Out
Call
2024-06-07 CALL at $245.00.07030.0159682024-06-070.0 - 4.50.26Out
 Put
2024-06-07 PUT at $305.0-0.98820.001102024-06-0768.2 - 78.00.0In
 Put
2024-06-07 PUT at $300.0-0.83040.004602024-06-0763.0 - 72.50.0In
 Put
2024-06-07 PUT at $295.0-0.81650.004902024-06-0758.0 - 67.90.0In
 Put
2024-06-07 PUT at $290.0-0.81030.005202024-06-0753.0 - 62.90.0In
 Put
2024-06-07 PUT at $285.0-0.80340.005602024-06-0748.0 - 57.90.0In
 Put
2024-06-07 PUT at $280.0-0.79780.00602024-06-0743.0 - 52.80.0In
 Put
2024-06-07 PUT at $275.0-0.79810.006602024-06-0738.0 - 47.40.0In
 Put
2024-06-07 PUT at $270.0-0.78790.007302024-06-0733.0 - 42.40.0In
 Put
2024-06-07 PUT at $265.0-0.76850.008102024-06-0728.0 - 37.70.0In
 Put
2024-06-07 PUT at $260.0-0.76380.009202024-06-0723.3 - 32.30.0In
 Put
2024-06-07 PUT at $255.0-0.75110.010702024-06-0718.6 - 27.10.0In
 Put
2024-06-07 PUT at $250.0-0.73370.012902024-06-0713.3 - 21.90.0In
 Put
2024-06-07 PUT at $247.5-0.72830.014502024-06-0711.0 - 19.10.0In
 Put
2024-06-07 PUT at $245.0-0.69150.015302024-06-078.4 - 17.30.0In
 Put
2024-06-07 PUT at $242.5-0.68770.018302024-06-076.2 - 14.20.0In
 Put
2024-06-07 PUT at $240.0-0.72780.026802024-06-075.1 - 10.00.0In
 Put
2024-06-07 PUT at $237.5-0.6260.024802024-06-071.65 - 9.30.0In
 Put
2024-06-07 PUT at $235.0-0.80630.082722024-06-072.7 - 4.03.0In
 Put
2024-06-07 PUT at $232.5-0.55420.118332024-06-071.55 - 2.151.6In
 Put
2024-06-07 PUT at $227.5-0.12780.051762024-06-070.0 - 3.10.26Out
 Put
2024-06-07 PUT at $225.0-0.09580.0309332024-06-070.0 - 4.40.25Out
 Put
2024-06-07 PUT at $220.0-0.1490.019172024-06-070.0 - 1.90.96Out
 Put
2024-06-07 PUT at $217.5-0.15970.0156102024-06-070.0 - 4.31.35Out
 Put
2024-06-07 PUT at $212.5-0.13820.0113102024-06-070.0 - 4.31.42Out

Biogen Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Biogen Total Stockholder Equity

Total Stockholder Equity

15.54 Billion

At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Biogen Corporate Executives

Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Michael CPAExecutive CFOProfile

Additional Information and Resources on Investing in Biogen Stock

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.011
Earnings Share
8
Revenue Per Share
66.688
Quarterly Revenue Growth
(0.07)
Return On Assets
0.0486
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.